Menu
← Oncology Approval Tracker
FDA DECISION ·
Paclitaxel protein-bound particles (HBT)
paclitaxel protein-bound particles (albumin-bound) · HBT Labs
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Albumin-bound paclitaxel suspension for specified metastatic breast cancer after prior treatment, initial advanced NSCLC in combination with carboplatin, and first-line metastatic pancreatic adenocarcinoma with gemcitabine.
LAMPGEN ANALYSIS
Why it matters
The product decision covers an albumin-bound formulation across three established treatment settings.
What research teams should watch
Verify the formulation, indication-specific schedule, and partner drug before substituting paclitaxel products.
PRIMARY RECORDS